Quest Capital Management, Inc . logo

Quest Capital Management, Inc .

North America, Texas, United States, Dallas

Description

Quest Capital Management provides its users with wealth management and financial planning services.

Investor Profile

Quest Capital Management, Inc . has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (33%)
  • Series C (33%)
  • Series A (33%)

Country Focus

  • United States (67%)
  • Switzerland (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Embedded Systems
  • Enterprise Software
  • Hardware
  • Software
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quest Capital Management, Inc . frequently co-invest with?

Alternative Investments Group
North America, Connecticut, United States, Southport
Co-Investments: 1
HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Scottish Equity Partners
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
Merifin Capital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Excalibur Fund Managers
Europe, England, United Kingdom, London
Co-Investments: 1
NV
North America, California, United States, Palo Alto
Co-Investments: 2
DC Thomson
Europe, Dundee City, United Kingdom, Dundee
Co-Investments: 1
BankInvest
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
QF
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
GeneChem
Asia, Taejon-jikhalsi, South Korea, Daejeon
Co-Investments: 1

What are some of recent deals done by Quest Capital Management, Inc .?

Cyclacel Pharmaceuticals

Berkeley Heights, New Jersey, United States

Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other critical diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DJan 29, 2004
Amount Raised: $38,677,484
Roche Glycart

Schlieren, Zurich, Switzerland

Roche Glycart is a biotechnology company, engages in the research, development, and commercialization of antibody-based products.

BiotechnologyHealth CareMedical
Series ANov 26, 2003
Amount Raised: $13,600,000
Anadigm

Mesa, Arizona, United States

Anadigm brings platform-based design to the analog world with prequalified software and hardware components.

Embedded SystemsEnterprise SoftwareHardwareSoftware
Series COct 2, 2003
Amount Raised: $15,000,000